Eleftherios P Mamounas MD

PubMed

• Expert Perspectives on Controversies and Critical Knowledge Gaps in Breast Cancer Management: Proceedings of the First Bridging the Gaps in Breast Cancer Symposium.
  Komal Jhaveri, Carey K Anders, Aditya Bardia, Manali Bhave, A Jo Chien
  Clinical Breast Cancer. 2025-08-01
• NRG-BR008/HERO study: a Phase III randomized trial of radiotherapy optimization for low-risk HER2-positive breast cancer.
  Lior Z Braunstein, Melissa P Mitchell, Hanna Bandos, William M Sikov, Atif J Khan
  Future Oncology. 2025-07-01
• 3 citations
  Breast Tumor-Bed Biopsy for Pathological Complete Response Prediction: The NRG-BR005 Nonrandomized Clinical Trial.
  Mark Basik, Reena S Cecchini, Jennifer F De Los Santos, Heidi R Umphrey, Thomas B Julian
  JAMA Surgery. 2025-07-01

Journal Articles

• 21-Gene Assay as Predictor of Chemotherapy Benefit in HER2-Negative Breast Cancer  
  Eleftherios P Mamounas, Frederick L Baehner, Norman Wolmark, D Lawrence Wickerham, Nature
• Clinical Relevance of the 21-Gene Recurrence Score® Assay in Treatment Decisions for Patients with Node-Positive Breast Cancer in the Genomic Era  
  Eleftherios Mamounas, MD, Nature

Lectures

• NRG Oncology/NSABP B-51/RTOG 1304: Phase III trial to determine if chest wall and regional nodal radiotherapy (CWRNRT) post mastectomy (Mx) or the addition of RNRT to ... 
  2019 ASCO Annual Meeting - 6/1/2019
• NRG Oncology/NSABP B-51/RTOG 1304: Phase III trial to determine if chest wall and regional nodal radiotherapy (CWRNRT) post mastectomy (Mx) or the addition of RNRT to ... 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018